These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10638210)

  • 1. [Autoimmune hyperchylomicronemia].
    Nozaki S; Matsuzawa Y
    Nihon Rinsho; 1999 Dec; 57(12):2765-9. PubMed ID: 10638210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune hyperchylomicronemia.
    Kihara S; Matsuzawa Y; Kubo M; Nozaki S; Funahashi T; Yamashita S; Sho N; Tarui S
    N Engl J Med; 1989 May; 320(19):1255-9. PubMed ID: 2785243
    [No Abstract]   [Full Text] [Related]  

  • 3. [Autoimmune hyperlipidemia].
    Kihara S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():119-23. PubMed ID: 11347042
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hematological disorder and hyperlipoproteinemia].
    Kihara S; Matsuzawa Y
    Nihon Rinsho; 1990 Nov; 48(11):2593-8. PubMed ID: 2270026
    [No Abstract]   [Full Text] [Related]  

  • 5. Rare case of autoimmune hyperchylomicronemia during pregnancy.
    Yoshimura T; Ito M; Sakoda Y; Kobori S; Okamura H
    Eur J Obstet Gynecol Reprod Biol; 1998 Jan; 76(1):49-51. PubMed ID: 9481547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a new case of autoimmune type I hyperlipidemia: long-term remission under immunosuppressive therapy.
    Pruneta V; Moulin P; Labrousse F; Bondon PJ; Ponsin G; Berthezene F
    J Clin Endocrinol Metab; 1997 Mar; 82(3):791-6. PubMed ID: 9062484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and function of anti-lipoprotein lipase auto-antibodies in type V hyperchylomicronemia.
    Moret M; Pruneta-Deloche V; Sassolas A; Marcais C; Moulin P
    Atherosclerosis; 2010 Feb; 208(2):324-7. PubMed ID: 19695572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia.
    Pruneta-Deloche V; Marçais C; Perrot L; Sassolas A; Delay M; Estour B; Lagarde M; Moulin P
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3995-8. PubMed ID: 15840743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auto-immune hyperlipidemia. An atherogenic metabolic disease of immune origin.
    Beaumont JL
    Rev Eur Etud Clin Biol; 1970 Dec; 15(10):1037-41. PubMed ID: 4931715
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-lipoprotein lipase antibodies in patients with hypertriglyceridemia without associated autoimmune disease.
    de Carvalho JF; Viana VS; Neto EF; Santos RD; Bonfá E
    Isr Med Assoc J; 2011 Jun; 13(6):350-3. PubMed ID: 21809732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipoprotein lipase inhibitory factor].
    Kihara S
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):88-90. PubMed ID: 9645015
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective deficiency of hepatic triglyceride lipase in uremic patients.
    Mordasini R; Frey F; Flury W; Klose G; Greten H
    N Engl J Med; 1977 Dec; 297(25):1362-6. PubMed ID: 200841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review on anti-lipoprotein lipase antibodies.
    Rodrigues CE; Bonfá E; Carvalho JF
    Clin Chim Acta; 2010 Nov; 411(21-22):1603-5. PubMed ID: 20673827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of hyperlipoproteinemias].
    Müller G
    Z Gesamte Inn Med; 1974 Jun; 29(12):469-76. PubMed ID: 4368206
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-lipoprotein autoantibodies with hypolipidemia in infectious rheumatism].
    Noseda G
    Schweiz Med Wochenschr; 1975; 105(31 Suppl):1-58. PubMed ID: 168637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotic syndrome, monoclonal gammopathy and auto-immune hyperlipidaemia.
    Beaumont JL; Antonucci M; Lagrue G; Guedon J; Perol R
    Clin Exp Immunol; 1974 Oct; 18(2):225-36. PubMed ID: 4468196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial hyperchylomicronemia: study of lipolytic activity in a family].
    Gagne C; Brun D; Moorjani S; Lupien PJ
    Union Med Can; 1977 Mar; 106(3):333-8. PubMed ID: 855024
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperchylomicronemia and hyperprebetalipoproteinemia. Study of the lipoprotein lipase system].
    Paluszak J; Sobisz S
    Pol Arch Med Wewn; 1972 Feb; 49(2):175-9. PubMed ID: 4362306
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical, biochemical, and familial presentation of type V hyperlipoproteinemia in childhood.
    Kwiterovich PO; Farah JR; Brown WV; Bachorik PS; Baylin SB; Neill CA
    Pediatrics; 1977 Apr; 59(4):513-25. PubMed ID: 191790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.